Shuttle Pharmaceuticals Holdings (SHPH) Payables (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Payables history runs 6 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• On a quarterly basis, Payables rose 97.18% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 97.18% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 97.42% from the prior year.
• Payables climbed to $1.8 million in Q1 2026 per SHPH's latest filing, from $1.6 million in the prior quarter.
• Across five years, Payables topped out at $1.8 million in Q1 2023 and bottomed at $233500.0 in Q4 2022.
• The 5-year median for Payables is $919523.0 (2025), against an average of $1.0 million.
• Across the five-year window, Payables tumbled 81.37% in 2022 and soared 163.03% in 2025, its largest moves.
• Year by year, Payables stood at $233500.0 in 2022, then jumped by 155.44% to $596445.0 in 2023, then jumped by 31.93% to $786870.0 in 2024, then jumped by 97.42% to $1.6 million in 2025, then advanced by 16.72% to $1.8 million in 2026.
• Per Business Quant, the three latest SHPH Payables figures stand at $1.8 million (Q1 2026), $1.6 million (Q4 2025), and $1.5 million (Q3 2025).